Gene Therapy Development 2024
13 - 14 June 2024 | London, UK

Join over 250 scientific leaders engaging in scientific discussions on the latest strategies and technologies to accelerate gene therapy production.

Gene Therapy Development 2024 delivers in-depth discussion on optimised process strategies and technologies for the successful technical development and manufacture of advanced gene therapy products.

3rd Annual Gene Therapy Development Congress

Benefits to attending include…

Connect with over 250 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. 

Gain insights into the innovative technologies in gene editing, including CRISPR, ZFNs and TALENS and the translation of these technologies to clinical research 

Featuring key case studies on advanced analytical strategies for gene therapy and vector development, to support the successful commercialisation of therapeutic products 

Maximise your experience with our fully featured Event App, with selected presentations available to watch on-demand and extensive networking features

This Year's Agenda at a Glance

Day One
  • Viral & non-viral vector safety & quality
  • Delivery and dosage challenges for gene therapies
  • Effective testing, characterisation & validation approaches
  • Technical development of viral & non-viral vector-based gene therapies
  • Scalable platforms for vector production
  • Scalable and cost-effective production processes
  • Process development for quality & greater vector yields
  • Improving titers & potency
  • Balancing speed-to-market and product quality
  • Strategies for scaling-up production
  • Internal vs external manufacturing
  • Successful commercialisation and launch of gene therapy products
  • CAR-T, TCR & Engineered NK cell therapies
  • Applications of gene therapy in clinical research
  • Discovery gene therapy for rare disorders: blood, neurology & ophthalmology disorders
  • Gene therapy in personalised medicine & patient treatment
  • Proof-of-concept studies- Phase 1 & 2
Day Two
  • Bioassays & analytical chemistry
  • Developing advanced analytical characterization methods
  • Comparability study challenges for gene therapy products
  • Tools to predict patient response to gene therapy
  • Impurity analysis during process development
  • Procurement of raw materials
  • Regulatory landscape for advanced therapies: distinctions between CAR-T and AAV
  • QA/QC Considerations
  • Emerging targets & discovery in Gene Therapy
  • CRISPR tools, ZFNs, TALENS
  • Translating gene editing to the clinic
  • Base-editing tools in gene editing
  • In vivo vs ex vivo gene editing
  • Standardisation & quality control for gene editing
  • How to best use gene editing for a given indication

Key Speakers

The 2024 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below are some of the key speakers of our Gene Therapy Development & Manufacturing 2024 event

Vice President Neurobiology, CNS Sector Lead, Askbio Paris Site Head
Asklepios BioPharmaceutical
Global Medical Director
Novartis Gene Therapies
Head of Gene Therapy
Medicine and Healthcare Products Regulatory Agency
Senior Director MSAT
Quell Therapeutics
Head of Vector Development
Sania Therapeutics
Chief Executive Officer and Co-Founder
Integra Therapeutics

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception

Event App

Our Event App features a personalisable agenda, peer-to-peer networking, OnDemand Presentations, solution provider content, and much more!

Thank you to our Sponsors

Oxford Global Conferences | Wyatt Technology
Bronze Sponsor
Oxford Global Conferences | Sartorius
Bronze Sponsor
Oxford Global Conferences | Samplix ApS
Bronze Sponsor
Bronze Sponsor
Silver Sponsor
Oxford Global Conferences | Bio-Rad Laboratories Ltd
Gold Sponsor
Oxford Global Conferences | SGS
Network & Programme Sponsor